Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Que., Canada

NeuroToxicology

Volumn 27, Issue 3, 2006, Pages 429-436

  Stamler, Christopher John ^a   Abdelouahab, Nadia ^b   Vanier, Claire ^b   Mergler, Donna ^b   Chan, Hing Man ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Dopamine; Methylmercury; Neurotoxicity; Noradrenaline; Serotonin; Surrogate biomarkers

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CADMIUM; LEAD; MANGANESE; MERCURY; SELENIUM; AMINE OXIDASE (FLAVIN CONTAINING);

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANADA; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; FISH; FOOD CONTAMINATION; HAIR ANALYSIS; HUMAN; LAKE; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; THROMBOCYTE; ADOLESCENT; ANIMAL; BLOOD; CHILD; COMPARATIVE STUDY; DEMOGRAPHY; ENZYMOLOGY; METHODOLOGY; MIDDLE AGED; POLLUTANT; PREDICTION AND FORECASTING; SPECTROFLUOROMETRY; STATISTICS;

ANIMALIA; MAMMALIA;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOOD PLATELETS; CHILD; ENVIRONMENTAL POLLUTANTS; FEMALE; FISHES; FOOD CONTAMINATION; HUMANS; MALE; MERCURY; MIDDLE AGED; MONOAMINE OXIDASE; PREDICTIVE VALUE OF TESTS; QUEBEC; RESIDENCE CHARACTERISTICS; SEX FACTORS; SPECTROMETRY, FLUORESCENCE;

EID: 33746900118     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2005.12.005     Document Type: Article

References (69)

1. Agency for Toxic Substance and Disease Registry (US) (ATSDR). Toxicological profile for mercury (1999), US Department of Health and Human Services, Public Health Service, Atlanta, GA 676 pp.
2. Bakir F., Damluji S.F., Amin-Zaki L., Murtadha M., Khalidi A., al-Rawi N.Y., et al. Methylmercury poisoning in Iraq. Science 181 (1973) 230-241
3. Berlin I., and Anthenelli R.M. Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 4 (2001) 33-42
4. Berntssen M.H., Aatland A., and Handy R.D. Chronic dietary mercury exposure causes oxidative stress, brain lesions, and altered behaviour in Atlantic salmon (Salmo salar) parr. Aquat Toxicol 65 (2003) 55-72
5. Bloom N., and Fitzgerald W.F. Determination of volatile mercury species at the picogram level by low temperature gas chromatography with cold vapour atomic fluorescence detection. Anal Chem Acta 208 (1988) 151-161
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
7. Cases O., Vitalis T., Seif I., De Maeyer E., Sotelo C., and Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16 (1996) 297-307
8. Castagnoli K., Steyn S.J., Magnin G., Van Der Schyf C.J., Fourie I., Khalil A., et al. Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase. Neurotoxicol Res 4 (2002) 151-160
9. Castoldi A.F., Coccini T., Ceccatelli S., and Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res Bull 55 (2001) 197-203
10. Chakrabarti S.K., Loua K.M., Bai C., Durham H., and Panisset J.C. Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. Neurotoxicol Teratol 20 (1998) 161-168
11. Chan H.M., and Egeland G.M. Fish consumption, mercury exposure, and heart diseases. Nutr Rev 62 (2004) 68-72
12. Chan H.M., Trifonopoulos M., Ing A., Receveur O., and Johnson E. Consumption of freshwater fish in Kahnawake: risks and benefits. Environ Res 80 (2000) S213-S222
13. Chen K., Wu H.F., and Shih J.C. The deduced amino acid sequence of human platelet and frontal cortex monoamine oxidase B are identical. J Neurochem 61 (1993) 187-190
14. Clarkson T.W., Hursh J.B., Sager P.R., and Syversen T. Mercury. In: Clarkson T.W., Friberg L., Nordberg G.F., and Sager P.R. (Eds). Biological monitoring of metals (1988), Plenum Press, New York 199-246
15. Costa L.G., Kaylor G., and Murphy S.D. Muscarinic cholinergic binding sites on rat lymphocytes. Immunopharmacology 16 (1988) 139-149
16. Costa L.G., and Manzo L. Biochemical markers of neurotoxicity: research strategies and epidemiological applications. Toxicol Lett 77 (1995) 137-144
17. Damberg M., Garpenstrand H., Hallman J., and Oreland L. Genetic mechanisms of behavior-don't forget about the transcription factors. Mol Psychiatry 6 (2001) 503-510
18. Dare E., Fetissov S., Hokfelt T., Hall H., Ogren S.O., and Ceccatelli S. Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 500-508
19. dell'Omo M., Muzi G., Piccinini R., Gambelunghe A., Morucci P., Fiordi T., et al. Blood cadmium concentrations in the general population of Umbria, central Italy. Sci Total Environ 226 (1999) 57-64
20. Faro L.R., Duran R., do Nascimento J.L., Alfonso M., and Picanco-Diniz C.W. Effects of methyl mercury on the in vivo release of dopamine and its acidic metabolites DOPAC and HVA from striatum of rats. Ecotoxicol Environ Saf 38 (1997) 95-98
21. Faro L.R., Duran R., Do Nascimento J.L., Perez-Vences D., and Alfonso M. Effects of successive intrastriatal methylmercury administrations on dopaminergic system. Ecotoxicol Environ Saf 55 (2003) 173-177
22. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996) 733-736
23. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93 (1996) 14065-14069
24. Ganther H.E., Goudie C., Sunde M.L., Kopecky M.J., and Wagner P. Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna. Science 175 (1972) 1122-1124
25. Gill U.S., Schwartz H.M., and Bigras L. Results of multiyear international interlaboratory comparison program for mercury in human hair. Arch Environ Contam Toxicol 43 (2002) 466-472
26. Gimenez-Llort L., Ahlbom E., Dare E., Vahter M., Ogren S., and Ceccatelli S. Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. Environ Toxicol Pharmacol 9 (2001) 61-70
27. Golino P., Ashton J.H., Buja L.M., Rosolowsky M., Taylor A.L., McNatt J., et al. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo: thromboxane A2 and serotonin are possible mediators. Circulation 79 (1989) 154-166
28. Gomes B., Kloepfer H.G., Oi S., and Yasunobu K.T. The reaction of sulfhydryl reagents with bovine hepatic monoamine oxidase: evidence for the presence of two cysteine residues essential for activity. Biochim Biophys Acta 438 (1976) 347-357
29. Gomes B., Naguwa G., Kloepfer H.G., and Yasunobu K.T. Amine oxidase. XV. The sulfhydryl groups of beef liver mitochondrial amine oxidase. Arch Biochem Biophys 132 (1969) 28-33
30. Hansen J.C., Deutch B., and Pedersen H.S. Selenium status in Greenland Inuit. Sci Total Environ 331 (2004) 207-214
31. Harada M. Minimata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 25 (1995) 1-24
32. Karita K., and Suzuki T. Fish eating and variations in selenium and mercury levels in plasma and erythrocytes in free-living healthy Japanese men. Biol Trace Elem Res 90 (2002) 71-81
33. Krajl M. A rapid microfluorometric determination of monoamine oxidase. Biochem Parmacol 14 (1965) 1683-1685
34. Lakshmana M.K., Desiraju T., and Raju T.R. Mercuric chloride-induced alterations of levels of noradrenaline, dopamine, serotonin and acetylcholine esterase activity in different regions of rat brain during postnatal development. Arch Toxicol 67 (1993) 422-427
35. Laliberté D. Évolution des teneurs en mercure et en BPC de quatre espèces de poissons du Saint-Laurent, 1976-1997. Ministère de l'Environnement, Québec, envirodoq no EN/2003/0287: Direction du suivi de l'état de l'environnement; 2003. p. 1-85.
36. Lenders J.W., Eisenhofer G., Abeling N.G., Berger W., Murphy D.L., Konings C.H., et al. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest 97 (1996) 1010-1019
37. Leung T.K., Lim L., and Lai J.C. Differential effects of metal ions on type A and type B monoamine oxidase activities in rat brain and liver mitochondria. Metab Brain Dis 7 (1992) 139-146
38. Lindstrom H., Luthman J., Oskarsson A., Sundberg J., and Olson L. Effects of long-term treatment with methyl mercury on the developing rat brain. Environ Res 56 (1991) 158-169
39. Magos L. Overview on the protection given by selenium against mercurials. In: Suzuki T., Imura N., and Clarkson T.W. (Eds). Advances in mercury toxicology (1991), Plenum Press, New York 289-298
40. Mahaffey K.R., and Mergler D. Blood levels of total and organic mercury in residents of the upper St. Lawrence River basin, Quebec: association with age, gender, and fish consumption. Environ Res 77 (1998) 104-114
41. Manzo L., Artigas F., Martinez E., Mutti A., Bergamaschi E., Nicotera P., et al. Biochemical markers of neurotoxicity: a review of mechanistic studies and applications. Hum Exp Toxicol 15 Suppl. 1 (1996) S20-S35
42. Manzo L., Castoldi A.F., Coccini T., and Prockop L.D. Assessing effects of neurotoxic pollutants by biochemical markers. Environ Res 85 (2001) 31-36
43. Mergler D. Review of neurobehavioral deficits and river fish consumption from the Tapajos (Brazil) and St. Lawerence (Canada). Environ Toxicol Pharmacol 12 (2002) 93-99
44. Mergler D., Belanger S., Larribe F., Panisset M., Bowler R., Baldwin M., et al. Preliminary evidence of neurotoxicity associated with eating fish from the Upper St. Lawrence River Lakes. Neurotoxicology 19 (1998) 691-702
45. Murphy D.L., and Kalin N.L. Biological and behavioural consequences of alterations in monoamine exidase activity. Schizophr Bull 6 (1980) 355-367
46. Najean Y., Ardaillou N., and Dresch C. Platelet lifespan. Annu Rev Med 20 (1969) 47-62
47. Nemecek G.M., Coughlin S.R., Handley D.A., and Moskowitz M.A. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83 (1986) 674-678
48. National Research Council (NRC). Committee on the toxicological effects of methylmercury (2000), National Academies Press, Washington, DC
49. Oudar P., Caillard L., and Fillion G. In vitro effect of organic and inorganic mercury on the serotonergic system. Pharmacol Toxicol 65 (1989) 245-248
50. Polgar J., Chung S.H., and Reed G.L. Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. Blood 100 (2002) 1081-1083
51. Reed G.L., Fitzgerald M.L., and Polgar J. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. Blood 96 (2000) 3334-3342
52. Rommelspacher H., May T., Dufeu P., and Schmidt L.G. Longitudinal observations of monoamine oxidase B in alcoholics: differentiation of marker characteristics. Alcohol Clin Exp Res 18 (1994) 1322-1329
53. Shellenberger M.K. Effects of early lead exposure on neurotransmitter systems in the brain. A review with commentary. Neurotoxicology 5 (1984) 177-212
54. Shih J.C. Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Neurotoxicology 25 (2004) 21-30
55. Shih J.C., and Thompson R.F. Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 65 (1999) 593-598
56. Smargiassi A., Mergler D., Bergamaschi E., Vettori M.V., Lucchini R., and Apostoli P. Peripheral markers of catecholamine metabolism among workers occupationally exposed to manganese (Mn). Toxicol Lett 77 (1995) 329-333
57. Stamler C.J., Basu N., and Chan H.M. Biochemical markers of neurotoxicity in wildlife and human populations: considerations for method development. J Toxicol Environ Health A 68 (2005) 1413-1429
58. Stern A.H. Estimation of the interindividual variability in the one-compartment pharmacokinetic model for methylmercury: implications for the derivation of a reference dose. Regul Toxicol Pharmacol 25 (1997) 277-288
59. Stern A.H. A review of the studies of the cardiovascular health effects of methylmercury with consideration of their suitability for risk assessment. Environ Res 98 (2005) 133-142
60. Svensson B.G., Schutz A., Nilsson A., Akesson I., Akesson B., and Skerfving S. Fish as a source of exposure to mercury and selenium. Sci Total Environ 126 (1992) 61-74
61. Tayebati S.K., El-Assouad D., Ricci A., and Amenta F. Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol 132 (2002) 147-155
62. Tsuzuki Y. Effect of chronic methylmercury exposure on activities of neurotransmitter enzymes in rat cerebellum. Toxicol Appl Pharmacol 60 (1981) 379-381
63. Van Oostdam J., Gilman A., Dewailly E., Usher P., Wheatley B., Kuhnlein H., et al. Human health implications of environmental contaminants in Arctic Canada: a review. Sci Total Environ 230 (1999) 1-82
64. Vikenes K., Farstad M., and Nordrehaug J.E. Serotonin is associated with coronary artery disease and cardiac events. Circulation 100 (1999) 483-489
65. Watanabe C. Modification of mercury toxicity by selenium: practical importance?. Tohoku J Exp Med 196 (2002) 71-77
66. Whitaker-Azmitia P.M., Zhang X., and Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology 11 (1994) 125-132
67. Whitfield J.B., Pang D., Bucholz K.K., Madden P.A., Heath A.C., Statham D.J., et al. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. Psychol Med 30 (2000) 443-454
68. World Health Organization (WHO). Environmental health criteria document 101-methylmercury (1990), World Health Organization, Geneva, Switzerland
69. Youdim M.B., Woods H.F., Mitchell B., Grahame-Smith D.G., and Callender S. Human platelet monoamine oxidase activity in iron-deficiency anaemia. Clin Sci Mol Med 48 (1975) 289-295